Cytomegalovirus infection enhances the immune response to influenza
Year: 2015
Type: article
Study design: Observational Study
Abstract: Cytomegalovirus (CMV) is a β-herpesvirus present in a latent form in most people worldwide. In immunosuppressed individuals, CMV can reactivate and cause serious clinical complications, but the effect of the latent state on healthy people remains elusive. We undertook a systems approach to understand the differences between seropositive and negative subjects and measured hundreds of immune system components from blood samples including cytokines and chemokines, immune cell phenotyping, gene expression, ex vivo cell responses to cytokine stimuli, and the antibody response to seasonal influenza vaccination. As expected, we found decreased responses to vaccination and an overall down-regulation of immune components in aged individuals regardless of CMV status. In contrast, CMV-seropositive young adults exhibited enhanced antibody responses to influenza vaccination, increased CD8(+) T cell sensitivity, and elevated levels of circulating interferon-γ compared to seronegative individuals. Experiments with young mice infected with murine CMV also showed significant protection from an influenza virus challenge compared with uninfected animals, although this effect declined with time. These data show that CMV and its murine equivalent can have a beneficial effect on the immune response of young, healthy individuals, which may explain the ubiquity of CMV infection in humans and many other species.
Source: Science Translational Medicine
Institutions: Stanford University, University of North Carolina at Chapel Hill, St. Jude Children's Research Hospital, Technion – Israel Institute of Technology, Rappaport Family Institute for Research in the Medical Sciences, University of Virginia, Stanford Medicine, Howard Hughes Medical Institute
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Howard Hughes Medical Institute, Ellison Medical Foundation, Stanford Center on Longevity, Georgia Clinical and Translational Science Alliance, Israel Science Foundation, National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Research Resources, National Center for Advancing Translational Sciences
Awards: G2292752806, Spectrum Stanford Center for clinical and Translational Research and Education, Stanford Center for Clinical and Translational Education and Research (SCCTER)UL1, G3480463756, Vaccination and infection: indicators of immunological health and responsiveness, G7273996763, G7362911406, Expression and proteomic characterization of risk loci in type 1 diabetes, Mechanisms to diversify repertoire and modify T cell activity after infection, G890124218, G9000125282
OpenAlex ID: W2098132870
